Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Inventory (2019 - 2026)

Outset Medical has reported Inventory over the past 7 years, most recently at $47.6 million for Q4 2025.

  • Quarterly Inventory fell 19.83% to $47.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $47.6 million through Dec 2025, down 19.83% year-over-year, with the annual reading at $47.6 million for FY2025, 19.83% down from the prior year.
  • Inventory was $47.6 million for Q4 2025 at Outset Medical, down from $49.3 million in the prior quarter.
  • Over five years, Inventory peaked at $61.6 million in Q2 2024 and troughed at $24.6 million in Q1 2021.
  • The 5-year median for Inventory is $49.3 million (2023), against an average of $48.2 million.
  • Year-over-year, Inventory soared 190.41% in 2021 and then decreased 19.83% in 2025.
  • A 5-year view of Inventory shows it stood at $39.2 million in 2021, then skyrocketed by 31.37% to $51.5 million in 2022, then decreased by 4.39% to $49.2 million in 2023, then grew by 20.67% to $59.4 million in 2024, then decreased by 19.83% to $47.6 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Inventory are $47.6 million (Q4 2025), $49.3 million (Q3 2025), and $52.2 million (Q2 2025).